Recruiting Interstitial Lung Disease Studies in Boston
About Interstitial Lung Disease Clinical Trials in Boston
Interstitial lung disease is a group of disorders characterized by progressive scarring of lung tissue, leading to breathlessness and reduced oxygen exchange. Causes include autoimmune diseases, environmental exposures, and unknown factors. Treatment includes antifibrotic medications and immunosuppressants.
There are currently 27 interstitial lung disease clinical trials recruiting participants in Boston, MA. These studies are seeking a combined 18,295 participants. Research is being sponsored by Boston Children's Hospital, George Washington University, Boston Medical Center and 17 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Interstitial Lung Disease Clinical Trials in Boston — FAQ
Are there interstitial lung disease clinical trials in Boston?
Yes, there are 27 interstitial lung disease clinical trials currently recruiting in Boston, MA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Boston?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Boston research site will contact you about next steps.
Are clinical trials in Boston free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Boston studies also compensate for your time and travel.
What interstitial lung disease treatments are being tested?
The 27 active trials in Boston are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial lung disease.
Data updated July 13, 2026 from ClinicalTrials.gov